CPAP Reduces Heart-related Mortality Up to 55%
A worldwide study of over one million patients with sleep apnea provides the strongest evidence to date that CPAP therapy not only alleviates OSA symptoms but can also prolong life.
A worldwide study of over one million patients with sleep apnea provides the strongest evidence to date that CPAP therapy not only alleviates OSA symptoms but can also prolong life.
Argon Medical Devices has enrolled the first patient in a US-based study exploring a novel catheter-based device for managing blood clots in the lungs.
The FDA says the approval marks the first systemic therapy for non–small cell lung cancer and pancreatic adenocarcinoma harboring NRG1 gene fusions.
Mallinckrodt has begun a national rollout of the INOmax Evolve DS delivery system, which is FDA-cleared to provide inhaled nitric oxide to certain neonatal ICU patients in order to improve oxygenation and reduce the need for extracorporeal membrane oxygenation.
The clearance broadens the applicability of the AlphaVac F1885 System in the non-surgical removal of thrombi or emboli from the venous vasculature.
Penn researchers compared lung transplant survival rates between hospital-based and independent donor care units.
Patients with chronic conditions like COPD and asthma are diagnosed with lung cancer significantly later than those without these conditions.